Results 71 to 80 of about 260 (87)

Characterization of Stone Events in Patients With Type 3 Primary Hyperoxaluria

Journal of Urology, 2023
Lisa Vaughan, Ramila A Mehta, Phillip J Schulte   +2 more
exaly  

Clinical features of genetically confirmed patients with primary hyperoxaluria identified by clinical indication versus familial screening

Kidney International, 2020
David J Sas, Felicity T Enders, Ramila A Mehta   +2 more
exaly  

Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1

New England Journal of Medicine, 2021
Yaacov Frishberg, Sally A Hulton, Michael J Koren   +2 more
exaly  

A report from the European Hyperoxaluria Consortium (OxalEurope) Registry on a large cohort of patients with primary hyperoxaluria type 3

Kidney International, 2021
Cristina Martín-Higueras, Dorrit E Jacob, Justine Bacchetta   +2 more
exaly  

Clinical implications of mutation analysis in primary hyperoxaluria type 1

Kidney International, 2004
Christiaan S Van Woerden, Jaap W Groothoff, Ronald J A Wanders   +2 more
exaly  

Pyridoxine effect in type I primary hyperoxaluria is associated with the most common mutant allele

Kidney International, 2005
Carla G Monico, Sandro Rossetti, Julie B Olson   +2 more
exaly  

Patients with primary hyperoxaluria type 2 have significant morbidity and require careful follow-up

Kidney International, 2019
Hessel Peters-Sengers, Florian Erger, Bodo B Beck   +2 more
exaly  

Novel therapeutic approaches in primary hyperoxaluria

Expert Opinion on Emerging Drugs, 2018
Cristina Martín-Higueras, Bernd Hoppe
exaly  

Specific Inhibition of Hepatic Lactate Dehydrogenase Reduces Oxalate Production in Mouse Models of Primary Hyperoxaluria

Molecular Therapy, 2018
Chengjung Lai, Cristina Martín-Higueras, Eduardo Salido   +2 more
exaly  

Nephrocalcinosis is a risk factor for kidney failure in primary hyperoxaluria

Kidney International, 2015
Xiaojing Tang, Eric J Bergstralh, Ramila A Mehta   +2 more
exaly